The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.117.6.533

Based on our results, we feel that all 5 of the antidepressants are effective agents and are generally superior to the amphetamines and phenothiazines in producing remission or relief of primary and secondary symptoms which comprise the depressive syndrome. Generally, the best response to the antidepressants occurs in patients with primary depressive reactions. Most patients with depressive features associated with schizophrenia or organic brain disorders experience significant improvement in depressive symptomatology without experience

No serious complications or side effects were produced by the drugs. Postural hypotension, excessive psychomotor stimulation and aggravation of schizophrenic symptomatology were the most bothersome side effects and it would appear that each drug has a similar capacity to cause these reactions. Neither hemopoietic nor hepatic toxicity was evidenced during our experience with the drugs.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.